| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 23 |
| 1 | ASPIRIN 325 MG | 20 |
| 2 | ASPIRIN 81 MG | 20 |
| 3 | ATORVASTATIN CALCIUM | 16 |
| 4 | EVOLOCUMAB | 16 |
| 5 | CLOPIDOGREL | 15 |
| 6 | ADALIMUMAB | 11 |
| 7 | ETANERCEPT | 11 |
| 8 | OMEPRAZOLE MAGNESIUM | 11 |
| 9 | RISANKIZUMAB-RZAA | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DISOPYRAMIDE PHOSPHATE | 1 | 0.0012 |
| 1 | SALSALATE | 1 | 0.0011 |
| 2 | MARALIXIBAT CHLORIDE | 1 | 0.0010 |
| 3 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 4 | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | 1 | 0.0008 |
| 5 | PSYLLIUM HUSK | 1 | 0.0007 |
| 6 | TENECTEPLASE | 1 | 0.0006 |
| 7 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 8 | MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN | 1 | 0.0005 |
| 9 | ZINC OXIDE OINTMENT | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 23 |
| 2 | PCSK9 Inhibitor [EPC] | 18 |
| 3 | Insulin Analog [EPC] | 16 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 16 |
| 5 | Corticosteroid [EPC] | 14 |
| 6 | Interleukin-23 Antagonist [EPC] | 13 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 12 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 11 |
| 9 | Proton Pump Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | PCSK9 Inhibitor [EPC] | 18 | 0.0007 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 4 | Anti-anginal [EPC] | 4 | 0.0004 |
| 5 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 6 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 7 | Photoenhancer [EPC] | 1 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |